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The aim of this study is to analyze the success of extraoral osseointegrated implants used to 
support and contain prosthesis designed to rehabilitate craniofacial deformities.
Method: This study was based on the retrospective assessment of charts from 59 patients submitted 
to cancer surgery and who received 164 extraoral implants to contain facial prosthesis.
Results: Among 164 implants, 42 were fixed in previously irradiated regions. Eight of the implants 
did not have osseointegration; and from these, 2 were fixed in irradiated bone. The result show 116 
(95.1%) successfully osseointegrated implants in non-irradiated sites. The success rate among 42 
implants fixed in previously irradiated bones was 40 (95.3%) osseointegrated implants.
Conclusion: The use of extraoral craniofacial implants represents a safe and effective approach to 
treat facial deformities as a support for the rehabilitation prosthesis. Radiotherapy treatment does 
not prevent osseointegration.
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INTRODUCTION
In the past, materials found in nature, such as clay, 
wood, horn and animal skin, gold and silver, were all used 
in attempts to restore facial loss of substance. After the 
industrial revolution, in mid-18th century, new materials 
started to be created and some, such as paper, paraffin, 
plastics, acrylic and finally, silicone, started to be utilized 
in the prosthetic reconstruction of facial mutilations1. 
The prosthesis were glued to the face or supported in 
eyeglasses frames.
Before 1969, time when Bränemark’s papers were 
published, there were attempts to use implants crossing the 
skin and fixing to bones - yielding very negative results - 
they were rejected by infection within a maximum time 
of 3 months2.
The clinical need of permanent percutaneous links 
is found not only to retain the prostheses, but it is also 
used in nephrology, cardiology, neurology, urology, oto-
rhinolaryngology, orthopedic surgery, plastic reconstruc-
tive surgery, and in many other clinical disciplines. This 
clearly depicts the universal need to develop and establish 
a permanent percutaneous anchor3.
This opportunity came up in 1965, with the studies 
from Prof. P. I. Brånemark, who was unable to remove 
from the bony structure of dogs a titanium capsule used 
to support a magnification lens used to observe blood 
circulation. Apparently, such capsule made a single bond 
with the bone. Soon after, Brånemark started a new line 
of research, which led to the revolutionary concepts of 
osseointegration, which spread to different fields of medi-
cine and dentistry. Research in dentistry started in 1965, 
and it was published in 1969 on osseointegrated titanium 
implants, aimed at replacing dental elements and allowed 
for a stable fixation on the bony structures of the maxillary 
teeth, crossing the gum. In 1977, after following clini-
cal trials for 12 years, the osseointegration concept was 
accepted by medical authorities in Sweden. In this same 
year, the concept was extrapolated to other regions of the 
face, with the implant crossing the skin and enabling an 
excellent method to anchor auditory devices and facial 
prostheses. The first clinical case was done in a hearing 
loss individual, used to anchor an external hearing aid. In 
1979, a second case served as anchor for the prosthetic 
ear of and individual who had lost his ear pinna because 
of a tumor ressection4,5. In 1995, the concept of facial 
prosthesis anchoring was also accepted by the American 
FDA (Food and Drug Administration).
However, with the advent of osseointegration, a 
number of limitations to its use cropped up during the 
first years of its applications. Individuals with diabetes 
mellitus, osteoporosis and, especially, irradiated patients, 
started to be advised against the implant. Radiotherapy 
was originally considered a contraindication to installing 
osseointegrated dental implants, as per published in the 
1988 consensus6. Concerned with the secondary effects 
that radiation causes to the maxillary teeth in doses 
higher than 55 Gy, especially osteonecrosis, the same 
concern was automatically transferred to the extraoral 
implants7.
Although the risk of osteoradionecrosis contraindi-
cates the use of implants as a means of support treatment 
for prosthesis, the benefit they bring about for patient 
rehabilitation is huge and cannot be downplayed. Of the 
losses in irradiated patients, the craniofacial regions are the 
most affected: frontal bone 50%; zygoma 20%; temporal 
bone 8%8.
The poor situation of the bony structure, usually 
modified by irradiation effects, may difficult osseointegra-
tion. The minimum trauma caused during bone perforation 
to place the implant can be a triggering factor for the onset 
of osteoradionecrosis, when carried out near the radio-
therapy sessions. Notwithstanding, these effects may be 
overcome by increasing the contact of the bony structures 
with the surface implants. Originally, the extraoral implant 
had a smooth and ground surface, which along time was 
modified by the need to increase contact between the 
bone and the implant. These changes were based on acid 
blasting, anodization, implant design changes, with the 
aim of enlarging its external area. The radiotherapy effect 
and the osteoporosis in elderly patients are mentioned 
as the main causes of implant failure. The study of 631 
implants installed on 107 irradiated individuals, within a 
25-year period, compared to a control group, showed that 
implant failure rates are higher after previous radiotherapy. 
High failure rates happen after high doses of radiotherapy, 
or a long time after the irradiation. The cranial regions 
most affected by radiotherapy were the frontal bone, the 
zygoma, mandible and maxilla. The lowest failure rates 
were found in the maxilla9.
Notwithstanding, hyperbaric oxygenation (HBO) is 
advised in order to avoid post-radiotherapy osteoradione-
crosis10. Studies carried out in the University of Götemburg 
showed that hyperbaric oxygen increases angiogenesis 
and metabolism, acting as a growth factor and bone tissue 
renovation. From the clinical standpoint, HBO enables a 
better implant osseointegration in irradiated bones; pro-
tection against osteoradionecrosis; surgical complication 
reduction and healing increase in irradiated tissues.
In a case review study which happened before 
1968, there were osteoradionecrosis rates (ORN) of 11.8%, 
compared to 5.4% after 1968. Such difference is associated 
with the fact that many radiotherapy units exchanged their 
orthovoltage devices for megavoltage and supervoltage 
in this period. Summaries from this last decade point to 
a 2.1% of osteoradionecrosis rate in previously irradiated 
patients. At the same time, dentists and radiotherapies 
became more aware as to radiotherapy secondary risks, 
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improving mouth care and avoiding adrenalin injection in 
post-radiotherapy surgeries11.
Irradiated tissues develop a tissue hypovascular-
hypocellular-hypoxia which does not spontaneously 
revascularize. The results from Marx et al.12 showed that 
angiogenesis after normobaric oxygenation was a complete 
failure, suggesting that in this case, oxygen is a drug which 
requires hyperbaric pressure in order to generate therapeutic 
effects on hypovascular irradiated tissues. The indicated 
level is 2.4 atmospheres (ATA). The simple increase of 
available oxygen to the cell tissue does not seem, by itself, 
to stimulate angiogenesis. The stimulus seems to stem more 
from the pressure to which oxygen is submitted. The angio-
genesis stimulus is mediated by macrophages which migrate 
and secrete a variety of biochemical messages, including a 
chemotactic angiogenesis factor in response to high levels 
of lactose existing within the wound spaces.
Osteoradionecrosis is biologically considered a 
complex of dead cells and the cellular functional reduc-
tion caused by the transfer of radiation energy. One study 
encompassing 536 patients enabled to analyze and classify 
three pathophysiological conditions for osteoradionecrosis: 
induced by initial trauma; induced by late trauma; and 
spontaneous. The results enabled to establish procedures 
recommended to delay radiation for 21 days after tissue da-
mage; one relative contraindication to damage the tissues 
during the course of radiotherapy; one recommendation 
for using hyperbaric oxygen before the tissue damage; 
and one strong recommendation to promote the cleaning 
of irradiated patients. The time interval between the ir-
radiation and the implant surgery has been considered 
important for graft survival.
The ideal time has not been yet established. From 
the viewpoint of the individuals, immediate rehabilitation 
is important and, therefore, the shorter the time between 
irradiation and implant surgery the better. From the view-
point of tumor biology, one must wait between 1 and 3 
years after tumor surgery to perform the implant surgery. 
From the radiobiological viewpoint, the optimum time 
will be when the tissue reactions after radiotherapy have 
declined and the healing phase is established, these are 
2 to 4 months after radiotherapy. When we consider the 
risk reduction by trauma on the irradiated tissues, the ideal 
time would be 6 months to 1.5 years after the irradiation13.
In Brazil, extraoral implants started to be employed 
as an element of prosthesis support in the rehabilitation 
of people with facial mutilation as of 1995. The implants 
utilized at the time were imported and represented a high 
rehabilitation cost.
In this study we analyzed 59 individuals mutilated 
by surgery to treat malignant tumors, who received ex-
traoral implants to support facial prostheses. Our main 
goal was to know the success rate of implants fixed on 
irradiated bones.
METHOD
This study was approved by the Ethics in Research 
Committee on April 9, 2010 - case number 0339/10.
We took the following information from the retros-
pective analysis of the charts from 59 individuals implanted 
and rehabilitated: patient identification, institution where 
the procedure was carried out, age, gender, comorbidities, 
reason for the deformity, deformity site, surgical treatment, 
radiotherapy treatment, pre-implant grafting, pre-implant 
hyperbaric oxygenation (HBO), and osseointegration 
success rate.
As for inclusion criterion, we considered all the 
charts or clinical files from individuals treated for malignant 
tumors and submitted to the extraoral implant fixation pro-
cedure, carried out by the team between 1995 and 2010.
The data studied was plotted in an Excel 201 for 
Windows for proper information storage. The statistical 
analyses were done by the Statistical Package for the Social 
Sciences (SPSS) version 19.0 software for Windows and 
the R-Program version 2.11.0.
For the quantitative variables (numeric) we calcu-
lated some summary measures, such as mean, median, 
minimum and maximum values, standard deviation. The 
qualitative variables (categorical) were analyzed by me-
ans of calculating the absolute and relative (percentage) 
frequencies.
The inferential analyses employed with the goal of 
confirming or refuting the evidence found in the descrip-
tive analysis were:
•	 Fisher’s Exact test and its extension to study the 
association between the final assessment (suc-
cess and failure); radiotherapy treatment before 
implant installation (yes/no); dose utilized in 
the radiotherapy treatment (50 Gy, 60 Gy).
•	 Mann-Whitney test (Siegel, 2006) in the com-
parison of the final assessment (success and 
failure) of the implants.
•	 Implant and prosthesis survival analysis is 
represented by the Kaplan-Meyer curve.
RESULTS
The 59 individuals who were part of this study were 
implanted by the same team of professionals.
For analysis purposes, we considered the 59 cases 
of tumor resection, which cell types found were 35 (59.3%) 
squamous cell carcinoma; 15 (25.4%) basal cell carcinoma; 
two (3.4%) melanoma; one (1.7%) mucoepidermoid car-
cinoma; one (1.7%) basal-squamous cell carcinoma; one 
(1.7%) hemangioma; one (1.7%) rhabdomyosarcoma; one 
(1.7%), retinoblastoma; one (1.7%), adenocarcinoma and 
one (1.7%) schwannoma.
None of the individuals were submitted to hyper-
baric oxygen (HBO).
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Four (6.7%) individuals were submitted to che-
motherapy; one (1.7%) before implant fixation and three 
afterwards (5.0%).
Of the 59 cancer-treated individuals, 14 (23.7%) 
were irradiated: 7 with 50 Gy and the other 7 with 60 Gy. 
Forty-two implants were installed in these 14 previously 
irradiated individuals. Eight (19.0%) were in the ear; 
34(81.0%) were in the orbit. None in the nasal region. 
Of these 42 implants, only two (4.7%) did not have os-
seointegration (Table 1). The success rate was 95.3% of 
osseointegrated implants.
Forty-five (76.3%) of the individuals were not irra-
diated (Table 2).
Inferential results revealed that the expected 
likelihood of implant success is not associated to the 
pre-radiotherapy treatment (p = 0.978). According to 
Figure 1, the success estimated curves for individuals sub-
mitted to radiotherapy compared to those who were not 
submitted to radiotherapy have a very similar behavior.
DISCUSSION
With osseointegration, special attention started to 
be paid to individuals who had been mutilated by cancer 
surgery, considering the possibility of obtaining a rigid 
Anchorage to support and retain facial prostheses.
Of the 59 individuals in this study, 41 were males 
and 18 were females.
The 59 cancer-treated individuals were considered 
in this study because of the possible need of having been 
treated with radiotherapy as coadjuvant to the surgical 
treatment. Fourteen (21.2%) of the individuals studied were 
submitted to radiotherapy before implant installation, in 
doses varying between 50 Gy for seven (50%) individuals 
and 60 Gy for seven other (50%) individuals.
Although HBO is an important factor to guarantee 
a greater likelihood of osseointegration in irradiated in-
dividuals, being reported as a stimulus to angiogenesis 
and metabolism, acting as bone tissue renovation and 
growth factor, preventing osteoradionecrosis11,12, none of 
the individuals were submitted to HBO. Its use has been 
difficult in our country, because of the limited number of 
hyperbaric chambers available and its high cost. Of the 
42 implants placed in 14 irradiated individuals, only two 
did not osseointegrated, resulting in a 95.3% success rate 
(Table 1). Of 122 implants placed in 45 non-irradiated in-
dividuals, only six did not have osseointegration, resulting 
in the 95.1% success rate (Table 2). These indices are very 
close, as per show non Figure 1.
Table 1. Irradiated individuals and rate of osseointegration success.
Anatomical region Number of individuals
Age (years) 
Mean (min-max)  Gender M/F
Number of 
installed implants
Number of 
lost implants
% of osseointegration 
success
Year 3 67.3 (52-76) 2/1 8 0 100.0%
Nasal 0 0 0 0 0 0
Orbital 11 53.4 (20-75) 7/4 34 2 94.1%
Total 14 56.4 (20-76) 9/5 42 2 95.3%
Table 2. Individuals with cancer who were not irradiated and rate of osseointegration success.
Anatomical region Number of individuals
Age (years) 
Mean (min-max) Gender M/F
Number of 
installed implants
Number of 
lost implants
Rate of osseointegration 
success
Year 1 43,0(43-43) 0/1 3 0 100.0%
Nasal 10 65,0(27-82) 7/3 16 2 87,5%
Orbital 34 64,4(25-90) 25/9 103 4 96,2%
Total 45 66,8(27-85) 32/13 122 6 95,1%
Figure 1. Rate of implant success according to radiotherapy.
These results are very coherent with other results 
published in the literature14-17. And such values are con-
sidered much better than the 10% of losses recorded in 
the first 20 years of extraoral implant dentistry. We may 
consider that there has really been much development in 
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implant dentistry in irradiated individuals as pertaining to 
surgical care, a proper post-surgical time to perform the 
implant, type of implant surface, hygienic care, following 
the radiation dose, besides the development of radiothera-
py devices, which went from orthovoltage to supervoltage.
CONCLUSION
Implants placed on previously irradiated surfaces 
have the same success rate as those placed on non-irra-
diated bone surfaces.
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